about
Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status EpilepticusPharmacotherapy for Status EpilepticusSeizures - just the tip of the iceberg: Critical care management of super-refractory status epilepticusTreatment of drug-induced seizuresIntravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice.NMDA antagonists for refractory seizures.Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABA(A) receptorsPerioperative care of a patient with neuronal ceroid lipofuscinoses.(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.Treatment of status epilepticus with ketamine, are we there yet?Managing the generalised tonic-clonic seizure and preventing progress to status epilepticus: a stepwise approach.Status epilepticus: an update.Treatment of convulsive status epilepticus in childhood: recommendations of the Italian League Against Epilepsy.Treatment of Super-Refractory Status Epilepticus.Pharmacologic treatment of status epilepticus.Treatment of super-refractory status epilepticus: the sooner the better with less adverse effectsKetamine for medically refractory status epilepticus after elective aneurysm clipping.Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.
P2860
Q26746873-84C1F0CA-B763-4D3A-B348-2337B5A5CCE1Q26796689-351FC198-D4BA-4054-977C-9A5FB18ED370Q28074293-6AD14631-3D5E-44CA-927E-FDE66CF5962BQ28387942-977F59A2-20E2-4B63-B0E9-EF7810E16267Q30411523-CD7CF647-7550-4497-B10A-642F44F41E95Q33408877-597B66C5-854A-496A-AA31-4DF4309A326EQ35092368-90A68ABC-CADA-42E4-BC5F-7F0F671E2A9AQ36410331-9312D6FA-3782-4AE9-82C9-FB1C70AE4044Q37133771-6CA18EBA-B722-438F-A339-1AF399908382Q37201609-4992917F-565C-41E4-ABCD-0E8ED8CD804CQ38040844-75F7747E-4C40-4994-AD43-833A96A188C5Q38100382-5F6105CC-FD2D-4EA3-B728-F4DFB858694CQ38101389-31B86FB2-3FBB-4ABB-957F-636E663839DDQ38107426-289AC94C-9673-4D98-AAAA-5EC32E65DF51Q38149918-C46C1DBF-0F5E-4095-B931-45765F388BC2Q38571983-FAD374E7-B9B0-482B-85F5-0F3C53658C25Q38656719-DE1109C0-289F-4669-8E2B-F69911ABE52FQ42140829-D396CDE6-ED7D-4E0D-A91E-2610AFE8D99FQ42261813-8985360E-A9A1-4946-A237-95E9BA2B107AQ46819272-6669BAF2-7DBB-4B74-86A3-332E04C5B611
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Early ketamine to treat refractory status epilepticus.
@en
Early ketamine to treat refractory status epilepticus.
@nl
type
label
Early ketamine to treat refractory status epilepticus.
@en
Early ketamine to treat refractory status epilepticus.
@nl
prefLabel
Early ketamine to treat refractory status epilepticus.
@en
Early ketamine to treat refractory status epilepticus.
@nl
P2860
P1433
P1476
Early ketamine to treat refractory status epilepticus.
@en
P2093
Andreas H Kramer
P2860
P2888
P304
P356
10.1007/S12028-011-9668-7
P577
2012-04-01T00:00:00Z